Here's a possible answer: Company Performance: Vertex Pharmaceuticals' financial results, including revenue, earnings, and profitability, influence investor confidence. Strong results typically lead to higher stock prices.

Broader Market Conditions: Overall market sentiment, economic growth, and global events impact investor appetite for risk. Positive conditions generally boost stock prices.

Clinical Trial Outcomes: Success or failure of Vertex's clinical trials for new drugs significantly affects investor expectations and the stock price. Positive trial data often drives the price up.

Regulatory Approvals: Approval of Vertex's drugs by regulatory bodies like the FDA increases market access and revenue potential, positively impacting the stock price.

Competition: The presence and success of competing drugs from other pharmaceutical companies can affect Vertex's market share and profitability, potentially lowering the stock price.

Investor Sentiment: News articles, analyst ratings, and social media discussions contribute to investor sentiment, which can drive short-term fluctuations in the stock price.

Interest Rates: Higher interest rates can make borrowing more expensive for companies and reduce investor willingness to invest in stocks, potentially decreasing the price.

Economic Data: Key economic indicators, such as inflation, unemployment rates, and GDP growth, can influence investor confidence and impact the stock price.